Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move- (CSE:
$CNNA.C) (CSE: $HUGE.C) (TSX: $TGOD.TO) (NYSE: $CGC) (CSE: $AGRO.C)
Delta, Kelowna, BC –May 7,
2019 (Investorideas.com Newswire) www.Investorideas.com, a
global news source covering leading sectors including marijuana and hemp stocks
and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/05071CNNA-HUGE-TGOD-CGC-AGRO.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In
today’s podcast I look at a few of the day’s earlier announcements.
CannaOne Technologies (CSE:
CNNA) gave
a brief update on the soon-to-launch online CBD
marketplace for Mexico in partnership with Manna Health Services SA de CV.
CannaOne is currently negotiating final terms of the formal service agreement
with Manna intended to be a revenue sharing arrangement subject to terms and
conditions expected to be fully defined in the near-term. It is predicted that
this online Mexican marketplace will begin operations sometime in the Fall of
2019 with such actual launch date dependent on when, and if, the Mexican
authorities ultimately permit the import and sale of CBD products within
Mexico.
CannaOne CEO Solomon Riby-Williams
stated, "The Mexico CBD marketplace branded 'Casa CBD', will be the home
of premium CBD products to service the massive Mexican market. BloomKit, our proprietary software, will
provide the technology foundation for this online buying platform and it is
with extreme confidence that we look ahead to acting in our role as a critical
service provider in the future of Casa CBD."
Pertaining to the Mexico, according to Marijuana Moment, lawmakers plan to use the summer recess, which begins May
1 and runs through August 31, to rework legislation to legalize recreational
marijuana throughout Mexico. This recess period is particularly important given
that the Supreme Court has imposed an October deadline to develop a countrywide
regulatory plan for cannabis and hemp.
FSD Pharma Inc. (CSE:
HUGE) (OTC:
FSDDF) and Solarvest BioEnergy Inc. (TSX-V:
SVS), a technology company that developed an
algal-based flexible production platform capable of producing health products,
announced today that they signed a definitive
collaborative research and development agreement. Under the agreement,
Solarvest will conduct research using its algal expression technology to
develop pharmaceutical-grade cannabinoids. FSD Pharma and Solarvest have made
investments into one another and FSD has the option to enter into an exclusive
license arrangement over a subset of the project and receive royalty rights
over all of the products that result from the project.
Solarvest will carry out a research
project using its algal expression system for the purpose of developing a proof
of concept that algae can express pharmaceutical-grade cannabinoids. FSD and
Solarvest have allocated an initial budget of $1,000,000 for the CBD research
project, over a two-year period, and created a joint scientific review
committee to assess progress of the project against budgets and timelines.
The Green Organic Dutchman Holdings Ltd. (TSX:
TGOD) (OTC:
TGODF) announced
today that the Company expects to release its
first quarter 2019 earnings on Tuesday, May 14, 2019, after market close. The
Company will hold a conference call conducted by Brian Athaide, Chief Executive
Officer, and Sean Bovingdon, Chief Financial Officer, at 9:00 am Eastern Time on May 15, 2019, to discuss first quarter 2019
results and future outlook.
Canopy Growth Corporation (TSX:
WEED) (NYSE:
CGC) introduced
Spectrum Therapeutics, a new global brand that will encompass all of the
Company's ongoing commercial medical and clinical research operations including
Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent
addition to Canopy Growth's medical portfolio, Bionorica SE-founded C3
Cannabinoid Compound Company ("C3"), a European leader in
cannabinoid-based medical therapies.
Incorporating these entities into one unified
ecosystem will integrate the Company's medical efforts as one global healthcare
enterprise. Spectrum Therapeutics now encompasses the production and
distribution of full-spectrum and single cannabinoid medical cannabis products;
industry-leading education, resources and support for patients and healthcare
practitioners; as well as pre-clinical and clinical research and the
development of cannabinoid-based medicines.
The recent acquisition of C3
will allow Spectrum Therapeutics to continue to advance leadership in medical
cannabis globally by further expanding its ability to empower physicians in
Europe and around the world with the knowledge and therapies drawn from a full
range of cannabinoid-based medicines. This includes dronabinol, C3's
cannabinoid pharmaceutical drug available in Germany, Austria, Switzerland, and
Denmark. Dronabinol, while integrated into the Spectrum Therapeutics commercial
offering, will continue to be marketed under C3's established and
recognized branding, Bionorica Ethics.
Agrios Global Holdings Ltd. (CSE:
AGRO) (OTCQB:
AGGHF) announced that
Yunnan Hua Ma Biological Development Co. Ltd. ("HMB"), a subsidiary
of Agrios Asia Holdings Limited has recently obtained an Industrial Hemp
Cultivation Permit in Yunnan Province, the People's Republic of China.
The Permit, grants HMB rights to
cultivate industrial hemp in the region and to transport industrial hemp seeds,
hemp raw materials, hemp stalk and their processed products. Yunnan was the
first province in China to allow hemp cultivation in 2010 and has since issued
licences for hemp cultivation on more than 220,000 mu (36,300+ acres).
HMB intends to grow 200mu (1mu = 667m2)
of Industrial hemp in the 2019 season. A smaller first crop is adequate to
continue HMB's development of hemp cultivation and to supply raw materials for
current biotechnology research which is focused on utilizing hemp fibers as a
bio-degradable alternative for the manufacture of single use disposable
utensils.
Both Federal and Provincial authorities
from Yunnan's capital, Kunming, have also granted HMB an Import & Export
Permit allowing for the direct import and export of goods, internationally as
allowable by China customs. In addition, a Food Trading Permit, allows HMB to
buy and sell pre-packaged and non-packaged food products, including speciality
foods, health foods and nutraceuticals, through both retail and wholesale
market channels.
HMB's acquisition of the three new permits
for cultivation, import/export and food trading provides an exciting
opportunity for Agrios' subsidiaries to join in the rapidly expanding trade of
hemp products in and out of China. China's exports of industrial hemp products
are projected to grow to US $1.5 billion by 2020, according to New Frontier
Data, an independent, technology-driven analytics company specializing in the
cannabis industry.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
